An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication

Weehuizen, Jesper M; Hoepelman, Andy I M

doi:https://doi.org/10.1111/eci.13297

An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication

DSpace/Manakin Repository

An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication

Weehuizen, Jesper M; Hoepelman, Andy I M

(2020) European Journal of Clinical Investigation, volume 50, issue 7

(Editorial)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Antiviral Agents/therapeutic use, Betacoronavirus, COVID-19, Chloroquine/therapeutic use, Coronavirus Infections/drug therapy, Electrocardiography, Hospitalization, Humans, Hydroxychloroquine/therapeutic use, Long QT Syndrome/chemically induced, Netherlands, Pandemics, Pneumonia, Viral/drug therapy, SARS-CoV-2, Severity of Illness Index, Treatment Outcome, Biochemistry, Clinical Biochemistry, Editorial, Randomized Controlled Trial

DOI: https://doi.org/10.1111/eci.13297

ISSN: 0014-2972

Publisher: Wiley-Blackwell

Note: Funding Information: The sponsor of this study is ZonMw; Netherlands organization for Health Research and Development. The study did not received any (financial) support from the pharmaceutical industry. There are no financial conflicts of interest to disclose. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

(Peer reviewed)